AEROSOLISEREDE FLUORQUINOLONER OG ANVENDELSER HERAF
摘要
Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
申请公布号
DK1901749(T3)
申请公布日期
2016.10.24
申请号
DK20060760146T
申请日期
2006.05.18
申请人
Raptor Pharmaceuticals Inc.
发明人
SURBER, Mark, W.;BOSTIAN, Keith, A.;LOMOVSKAYA, Olga;GRIFFITH, David, C.;DUDLEY, Michael, N.